[1] Berger AM, Mooney K, Alvarez-Perez A, et al. Cancer-Related Fatigue, Version 2.2015 [J]. J Natl Compr Canc Netw, 2015, 13(8): 1012-1039.
[2] Charalambous A, Kouta C. Cancer related fatigue and quality of life in patients with advanced prostate cancer undergoing chemotherapy [J]. Biomed Res Int, 2016, 2016: 3989286.
[3] Abrahams HJ, Smits L, Luqt M, et al. Severe fatigue after treatment of ductal carcinoma in situ: A comparison with age-matched breast cancer survivors and healthy controls [J]. Breast, 2016, 31: 76-81.
[4] Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation [J]. Cancer, 2006, 106(4): 751-758.
[5] Jones JM, Olson K, Catton P, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors [J]. J Cancer Surviv, 2016, 10(1): 51-61.
[6] Bower JE, Ganz PA, Dickerson SS, et al. Diurnal cortisol rhythm and fatigue in breast cancer survivors [J]. Psychoneuroendocrinology, 2005, 30(1): 92-100.
[7] Singh H, Arya S, Talapatra P, et al. Assessment of fatigue in rheumatoid arthritis (by Functional Assessment of Chronic Illness Therapy-Fatigue score) and its relation to disease activity and anemia [J]. J Clin Rheumatol, 2014, 20(2): 87-90.
[8] Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors [J]. Brain Behav Immun, 2007, 21(7): 863-871.
[9] 李朝霞,米登海,温志震. 癌因性疲乏与炎症因子水平及其基因多态性[J]. 现代肿瘤医学, 2016, 24(2): 318-321.
[10] Wu HS, Davis JE, Natavio T. Fatigue and disrupted sleep-wake patterns in patients with cancer: a shared mechanism [J]. Clin J Oncol Nurs, 2012, 16(2): E56-E68.
[11] Dantzer R, Heijnen CJ, Kavelaars A, et al. The neuroimmune basis of fatigue [J]. Trends Neurosci, 2014, 37(1): 39-46.
[12] Al-Majid S, Waters H. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise [J]. Biol Res Nurs, 2008, 10(1): 7-20.
[13] Engen DJ, McAllister SJ, Whipple MO, et al. Effects of transdermal magnesium chloride on quality of life for patients with fibromyalgia: a feasibility study [J]. J Integr Med, 2015, 13(5): 306-313.
[14] Bower JE. Cancer-related fatigue－mechanisms, risk factors, and treatments [J]. Nat Rev Clin Oncol, 2014, 11(10): 597-609.
[15] Posener JA, Schildkraut JJ, Samson JA, et al. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects [J]. Psychoneuroendocrinology, 1996, 21(1): 33-38.
[16] Matsuo N, Morita T, Matsuda Y, et al. Predictor of responses to corticosteroids for cancer-related fatigue in advanced cancer patients: a multicenter, prospective, observational study [J]. J Pain Symptom Manage, 2016, 52(1): 64-72.
[17] Yiu YM, Ng SM, Tsui YL, et al. A clinical trial of acupuncture for treating chronic fatigue syndrome in Hong Kong [J]. Zhong Xi Yi Jie He Xue Bao, 2007, 5(6): 630-633.
[18] Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome [J]. J Clin Endocrinol Metab, 1991, 73(6): 1224-1234.
[19] Capuron L, Raison CL, Musselman DL, et al. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy [J]. Am J Psychiatry, 2003, 160(7): 1342-1345.
[20] Abercrombie HC, Giese-Davis J, Sephton S, et al. Flattened cortisol rhythms in metastatic breast cancer patients [J]. Psychoneuroendocrinology, 2004, 29(8): 1082-1092.
[21] Weinrib AZ, Sephton SE, Degeest K, et al. Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer [J]. Cancer, 2010, 116(18): 4410-4419.
[22] Schrepf A, Clevenger L, Christensen D, et al. Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability [J]. Brain Behav Immun, 2013, 30(Suppl): S126-S134.
[23] Ratnasingam J, Karim N, Paramasivam SS, et al. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors [J]. Pituitary, 2015, 18(4): 448-455.
[24] Hoyt MA, Marin-Chollom AM, Bower JE, et al. Approach and avoidance coping: diurnal cortisol rhythm in prostate cancer survivors [J]. Psychoneuroendocrinology, 2014, 49: 182-186.
[25] Follin C, Wiebe T, Moell C, et al. Moderate dose cranial radiotherapy causes central adrenal insufficiency in long-term survivors of childhood leukaemia [J]. Pituitary, 2014, 17(1): 7-12.
[26] Bower JE, Ganz PA, Aziz N, et al. Fatigue and proinflammatory cytokine activity in breast cancer survivors [J]. Psychosom Med, 2002, 64(4): 604-611.
[27] Bower JE, Ganz PA, Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue [J]. Psychosom Med, 2005, 67(2): 277-280.
[28] Schmidt ME, Semik J, Habermann N, et al. Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients [J]. Brain Behav Immun, 2016, 52: 98-105.
[29] Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain [J]. Nat Rev Neurosci, 2008, 9(1): 46-56.
[30] Greenberg DB, Gray JL, Mannix CM, et al. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer [J]. J Pain Symptom Manage, 1993, 8(4): 196-200.
[31] Collado-Hidalgo A, Bower JE, Ganz PA, et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors [J]. Clin Cancer Res, 2006, 12(9): 2759-2766.
[32] McEwen BS, Biron CA, Brunson KW, et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions [J]. Brain Res Brain Res Rev, 1997, 23(1-2): 79-133.
[33] Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders [J]. Am J Psychiatry, 2003, 160(9): 1554-1565.
[34] Bower JE, Ganz PA, Aziz N, et al. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids [J]. Brain Behav Immun, 2007, 21(3): 251-258.
[35] Bower JE, Ganz PA, Irwin MR, et al. Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue [J]. Brain Behav Immun, 2011, 25(1): 147-150.
[36] Jung M, Zepf N, Fuchs B. Exercise therapy for children with cancer related fatigue [J]. Klin Padiatr, 2016, 228(3): 157-163.
[37] LaVoy EC, Fagundes CP, Dantzer R. Exercise, inflammation, and fatigue in cancer survivors [J]. Exerc Immunol Rev, 2016, 22: 82-93.
[38] Hinkel JM. NCCN survey identifies cancer-related fatigue as an area of need for education [EB/OL]. [2016-07-05]. http://www.nccn.org/about/news/ebulletin/2009-07-06/survey.asp.
[39] Paulsen O, Klepstad P, Rosland JH, et al. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomised, placebo-controlled, double-blind trial [J]. J Clin Oncol, 2014, 32(29): 3221-3228.
[40] Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer [J]. J Clin Oncol, 2013, 31(25): 3076-3082.
[41] Begley S, Rose K, O'Connor M. The use of corticosteroids in reducing cancer-related fatigue: assessing the evidence for clinical practice [J]. Int J Palliat Nurs, 2016, 22(1): 5-9.
[42] 蒋超南,张美芬,张俊娥,等. 胃癌术后病人化疗期间癌因性疲乏的调查分析[J]. 全科护理, 2015, 13(19): 1890-1892.
[43] 王海明,方凡夫,黄枫,等. 消化道肿瘤患者癌因性疲乏中医证候研究[J]. 中医药导报, 2015, 21(9): 12-15.
[44] 于硕,张文洁,郝芳,等. 参芪扶正注射液对癌因性疲乏中肾上腺皮质作用的研究[J].中国肿瘤临床, 2013, 40(11):621-624, 633.
